检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:褚娜利[1] 张新华[2] 吴志奎[1] 王荣新[2] 王文娟[3] 王蕾[1] 方素萍[1] 程艳玲[1] 柴立民[4] 张冲[1] 刘莉[1] 刘咏梅[1] 李敏[1] 尹晓林[2] 黄有文[2] 李平萍[2] 黄洁[2]
机构地区:[1]中国中医科学院广安门医院,100053 [2]中国人民解放军第303医院,530021 [3]首都医科大学,100069 [4]北京中医药大学东直门医院,100700
出 处:《医学研究杂志》2015年第5期48-51,共4页Journal of Medical Research
基 金:国家重点基础研究发展计划("973"计划)基金资助项目(2010CB530406);国家自然科学基金资金项目(81173167;904090039;301711990;39270857);国家新药专项基金资助项目(2009ZX 09301-005-2-7);广西自然科学基金资助项目(2012GXNSFAA053156;2012GXNSFDA053018)
摘 要:目的评价益髓生血颗粒(Yisui Shengxue granule,YSSXG)治疗血红蛋白H病(HbH病)的临床疗效。方法自1989-2013年1月,采用补肾益髓代表方益髓生血颗粒治疗HbH病共237例,其中缺失型HbH病62例,非缺失型HbH病175例,疗程3个月,动态检测237例患者治疗前后的血液指标[血红蛋白(rib)、红细胞(RBC)、网织红细胞(Ret)]水平的变化,并对其中206例HbH患者治疗前后的中医症候(面色萎黄、头晕目眩、心慌心悸、动则气喘、潮热盗汗、口咽干燥、腰膝酸软)进行中医症候量化评分,观察益髓生血颗粒的临床治疗效果。结果HbH病患者自服药第1一第3个月,血液指标Hb、RBC与疗前相比均显著提高(P〈0.01)。经益髓生血颗粒治疗3个月,HbH病患者面色萎黄、头晕目眩、心慌心悸、动则气喘、潮热盗汗、口咽干燥、腰膝酸软的中医症候量化评分与疗前相比显著降低,临床症状显著改善。237例HbH病患者经3个月治疗后,总有效率为74.26%;其中缺失型HbH患者有效率为72.00%;非缺失型患者的有效率为80.65%。两种型别的HbH病患者的有效率比较,差异无统计意义。结论补肾益髓代表方益髓生血颗粒治疗HbH病疗效显著,提高HbH病患者Hb、RBC水平,同时能改善HbH病患者的中医症候。血液指标水平的提高和中医症状改善相一致。Objective To evaluate the clinical efficacy of Yisui Shengxue granule (YSSXG) in treating hemoglobin H disease. Methods Self- coss - referred trials were adopted in treating 237 cases of patients with hemoglobin H disease(62 cases of patients with deletional HbH disease and 175 cases of nondeletional HbH disease)with Yisui Shengxue granule (YSSXG)for 3 months. The blood pa- rameters including hemoglobin( Hb), red blood cells( RBC), reticulocyte(Ret) and seven TCM symptoms and TCM symptom score chan- ges were tested dynamically every month. Results The levels of Hb and RBC of 237 patients with hemoglobin H disease were significantly increased after YSSXG treatment from the first month to the end of treatment(P 〈 O. 01 ). The TCM symptom values of pale complexion, dizziness, tidal fever and night sweating, short of breath, dry throat, palpitations, soreness and weakness of waist and knees in 237 patients with hemoglobin H disease were lower than the values before treatment( P 〈 0.01 ). For the 237 cases of hemoglobin H disease patients af- ter three months of treatment, the total effective rate was 74.26% , which was 72.00% in patients with gene deletion and 80.65% in pa- tients with gene non - deletion. The efficacy difference of two types of patients was not statistically significant. Conclusion YSSXG is ef- fective in treatment of hemoglobin H disease. YSSXG can not only improve the levels of Hb and RBC but also can improve TCM symptoms in patients with hemoglobin H disease. The improved blood parameters were consistent with the TCM symptoms.
分 类 号:R55[医药卫生—血液循环系统疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:18.118.207.174